Catalyst Wire Dossier Catalyst Wire Dossier

SUBLIVAC Phleum

null · HAL Allergy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SUBLIVAC Phleum, covering 2019-09-13 to 2019-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy [Phase 2]

See pricing